Monday, January 10, 2022 4:17:08 PM
New York Yankees and Duke Basketball
Recent MOLN News
- Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit • GlobeNewswire Inc. • 06/17/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/14/2024 02:44:18 PM
- Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024 • GlobeNewswire Inc. • 06/14/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/11/2024 02:16:45 PM
- Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024 • GlobeNewswire Inc. • 06/11/2024 05:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2024 09:06:11 PM
- Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024 • GlobeNewswire Inc. • 06/01/2024 12:00:00 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:37 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 08:00:40 PM
- Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program • GlobeNewswire Inc. • 05/16/2024 08:00:00 PM
- Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action • GlobeNewswire Inc. • 04/29/2024 03:00:00 PM
- Life Science Cares Launches in Switzerland • GlobeNewswire Inc. • 04/19/2024 03:12:41 PM
- Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting • GlobeNewswire Inc. • 04/17/2024 03:12:16 PM
- Molecular Partners Publishes Invitation to Annual General Meeting 2024 • GlobeNewswire Inc. • 03/26/2024 01:26:32 PM
- Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023 • GlobeNewswire Inc. • 03/14/2024 08:00:00 PM
- Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations • GlobeNewswire Inc. • 03/01/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 05:33:05 PM
- Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2024 09:00:06 PM
- Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies • GlobeNewswire Inc. • 01/05/2024 09:00:00 PM
- Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences • GlobeNewswire Inc. • 12/14/2023 06:00:00 AM
- Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting • GlobeNewswire Inc. • 12/10/2023 05:00:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM